Defective circulating CD25 regulatory T cells in patients with chronic immune thrombocytopenic purpura.

Blood
Jin YuKarina Yazdanbakhsh

Abstract

Immune thrombocytopenic purpura (ITP) is characterized by the presence of antiplatelet autoantibodies as a result of loss of tolerance. CD4+CD25+ regulatory T cells (Tregs) are important for maintenance of peripheral tolerance. Decreased levels of peripheral Tregs in patients with ITP have been reported. To test whether inefficient production or reduced immunosuppressive activity of Tregs contributes to loss of tolerance in patients with chronic ITP, we investigated the frequency and function of their circulating CD4+CD25(hi) Tregs. We found a com-parable frequency of circulating CD4+CD25(hi)Foxp3+ Tregs in patients and controls (n = 16, P > .05). However, sorted CD4+CD25(hi) cells from patients with chronic ITP (n = 13) had a 2-fold reduction of in vitro immunosuppressive activity compared with controls (n = 10, P < .05). The impaired suppression was specific to Tregs as shown by cross-mixing experiments with T cells from controls. These data suggest that functional defects in Tregs contribute to breakdown of self-tolerance in patients with chronic ITP.

References

Jul 24, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·C Baecher-AllanD A Hafler
Jan 10, 2002·The Journal of Clinical Investigation·Anjli KukrejaNoel Maclaren
Jan 11, 2003·Science·Shohei HoriShimon Sakaguchi
Mar 4, 2003·Nature Immunology·Jason D FontenotAlexander Y Rudensky
Sep 3, 2003·European Journal of Haematology·Hatsue OgawaraHirokazu Murakami
Nov 6, 2003·Journal of Autoimmunity·Jose C CrispinJorge Alcocer-Varela
Dec 10, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Helmut Jonuleit, Edgar Schmitt
Apr 7, 2004·The Journal of Experimental Medicine·Vissia VigliettaDavid A Hafler
May 7, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ismé M de KleerBerent Prakken
Jul 15, 2004·Current Opinion in Pharmacology·Claire Thompson, Fiona Powrie
Mar 1, 2006·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Petra HoffmannMatthias Edinger
Oct 28, 2006·Thrombosis Research·Miho SakakuraHiroshi Shiku
Mar 3, 2007·European Journal of Haematology·Bin LiuZhong Chao Han
Apr 17, 2007·Seminars in Immunology·Thomas Korn, Mohamed Oukka
Aug 2, 2007·Hematology/oncology Clinics of North America·Bethan Psaila, James B Bussel
Oct 31, 2007·Nature Clinical Practice. Rheumatology·Xavier Valencia, Peter E Lipsky

❮ Previous
Next ❯

Citations

Jul 26, 2011·Annals of Hematology·Bob OlssonHans Wadenvik
Dec 10, 2009·Journal of Clinical Immunology·Xiaojuan ZhuMing Hou
Nov 23, 2013·Frontiers of Medicine·Xinguang LiuJun Peng
May 25, 2013·International Journal of Hematology·Hirokazu Kashiwagi, Yoshiaki Tomiyama
Mar 26, 2011·Nature Reviews. Immunology·John W SempleJohn Freedman
Jul 26, 2008·The Journal of Clinical Investigation·Bethan Psaila, James B Bussel
Jan 18, 2011·Hematology·Adam Cuker, Douglas B Cines
Mar 14, 2009·Blood·John W Semple
Jun 23, 2011·Paediatric Drugs·Amy Lee BredlauGeorge B Segel
Dec 24, 2013·Clinical & Developmental Immunology·Jiaming LiChanggeng Ruan
Jul 6, 2014·Human Immunology·Yanhui YangRenchi Yang
Oct 12, 2014·Human Immunology·Zhenping ChenRunhui Wu
Mar 26, 2010·Annals of Hematology·John W Semple
Mar 26, 2010·Expert Opinion on Therapeutic Targets·Daoxin MaMing Hou
Feb 3, 2016·Critical Reviews in Oncology/hematology·Ning-Ning ShanYing Li
Jul 14, 2012·Thrombosis Research·Shinya FujitaShosaku Nomura
Mar 15, 2011·Experimental Hematology·Laurent DetalleJean-Paul Coutelier
Jun 19, 2010·La Revue de médecine interne·S AudiaB Bonnotte
Jul 14, 2010·Best Practice & Research. Clinical Haematology·Clive S Zent, Neil E Kay
Apr 10, 2010·Critical Reviews in Oncology/hematology·Tingting WangRenchi Yang
Aug 11, 2015·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Ali EserTulin Firatli-Tuglular
Nov 3, 2009·Cytotherapy·Jose Antonio Pérez-SimónJesús F San Miguel
Nov 21, 2015·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Emil Kofod-OlsenTrine H Mogensen
Nov 28, 2014·Immunologic Research·Carlo PerriconeGuido Valesini
Jan 24, 2009·Pediatric Blood & Cancer·George B Segel, Stephen A Feig
Aug 25, 2015·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·BurenbatuHaihua Bai

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.